These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23745479)

  • 1. A multicenter, multidisciplinary, high-alert medication collaborative to improve patient safety: the Singapore experience.
    Khoo AL; Teng M; Lim BP; Tai HY; Lau TC
    Jt Comm J Qual Patient Saf; 2013 May; 39(5):205-12. PubMed ID: 23745479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-alert medications in the pediatric intensive care unit.
    Franke HA; Woods DM; Holl JL
    Pediatr Crit Care Med; 2009 Jan; 10(1):85-90. PubMed ID: 19057440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An internal quality improvement collaborative significantly reduces hospital-wide medication error related adverse drug events.
    McClead RE; Catt C; Davis JT; Morvay S; Merandi J; Lewe D; Stewart B; Brilli RJ;
    J Pediatr; 2014 Dec; 165(6):1222-1229.e1. PubMed ID: 25304926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a Swiss adverse drug event prevention collaborative.
    Staines A; Mattia C; Schaad N; Lécureux E; Bonnabry P
    J Eval Clin Pract; 2015 Aug; 21(4):717-26. PubMed ID: 26011777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving medication safety across a multihospital system.
    Farbstein K; Clough J
    Jt Comm J Qual Improv; 2001 Mar; 27(3):123-37. PubMed ID: 11242719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventability of Voluntarily Reported or Trigger Tool-Identified Medication Errors in a Pediatric Institution by Information Technology: A Retrospective Cohort Study.
    Stultz JS; Nahata MC
    Drug Saf; 2015 Jul; 38(7):661-70. PubMed ID: 26013909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Identify Organizational High-Alert Medications.
    Schepel L; Lehtonen L; Airaksinen M; Lapatto-Reiniluoto O
    J Patient Saf; 2021 Dec; 17(8):e1358-e1363. PubMed ID: 29994819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
    Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
    Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-alert medications in a French paediatric university hospital.
    Bataille J; Prot-Labarthe S; Bourdon O; Joret P; Brion F; Hartmann JF
    J Eval Clin Pract; 2015 Apr; 21(2):262-70. PubMed ID: 25560989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps.
    Greenwald JL; Halasyamani L; Greene J; LaCivita C; Stucky E; Benjamin B; Reid W; Griffin FA; Vaida AJ; Williams MV
    J Hosp Med; 2010 Oct; 5(8):477-85. PubMed ID: 20945473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a high-alert medication program.
    Graham S; Clopp MP; Kostek NE; Crawford B
    Perm J; 2008; 12(2):15-22. PubMed ID: 21364807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview.
    Acheampong F; Anto BP
    BMC Health Serv Res; 2015 Sep; 15():361. PubMed ID: 26345278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm.
    Seddon ME; Jackson A; Cameron C; Young ML; Escott L; Maharaj A; Miller N
    N Z Med J; 2012 Jan; 126(1368):9-20. PubMed ID: 23385830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing harm from high-alert medications.
    Federico F
    Jt Comm J Qual Patient Saf; 2007 Sep; 33(9):537-42. PubMed ID: 17915527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety implications of the dose change alert function in smart infusion pumps on the administration of high-alert medications.
    Goulding C; Bedard M
    Can J Crit Care Nurs; 2015; 26(4):23-7. PubMed ID: 26837122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
    Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
    Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.